The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 2, 2011, Pages 166-171

  Singh, Sheldon M ^a   Douglas, Pamela S ^b   Reddy, Vivek Y ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Atrial septal defect; Transseptal catheterization

Indexed keywords

AGED; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; CONTRAST ENHANCEMENT; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART CATHETER; HEART CATHETERIZATION; HEART LEFT RIGHT SHUNT; HUMAN; IATROGENIC ATRIAL SEPTAL DEFECT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSSEPTAL CATHETERIZATION; TREATMENT OUTCOME; CATHETER; CHI SQUARE DISTRIBUTION; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; EQUIPMENT DESIGN; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM; HEART INJURY; HEMODYNAMICS; IATROGENIC DISEASE; INCIDENCE; INJURY; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL SEPTUM; CATHETERS; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EQUIPMENT DESIGN; FEMALE; HEART CATHETERIZATION; HEART INJURIES; HEMODYNAMICS; HUMANS; IATROGENIC DISEASE; INCIDENCE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79958827076     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.959015     Document Type: Article

References (14)

1. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, for the PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a non-inferiority randomized trial. Lancet. 2009;374:534-542.
2. Reddy VY, Neuzil P, Themistoclakis S, Danik SB, Bonso A, Rossillo A, Raviele A, Schweikert R, Ernst S, Kuck KH, Natale A. Visually guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome. Circulation. 2009;120: 12-20.
3. Schmidt B, Tilz R, Kars Neven K, Chun KR, Fuernkranz A, Ouyang F. Remote robotic navigation and electroanatomical mapping for ablation of atrial fibrillation: considerations for navigation and impact on procedural outcome. Circ Arrhythm Electrophysiol. 2009;2: 120-128.
4. Obel O, Mansour M, Picard M, Ruskin J, Keane D. Persistence of septal defects after transseptal puncture for pulmonary vein isolation procedures. Pacing Clin Electrophysiol. 2004;27:1411-1414. (Pubitemid 39463660)
5. Hammerstingl C, Likfett L, Jeong KM, Troatz C, Wedekind JA, Tiemann K, Luderitz B, Lewalter T. Persistence of iatrogenic atrial septal defect after pulmonary vein isolation: an underestimated risk? Am Heart J. 2006;152:362.e1-362.e5.
6. Rilling A, Meyerfeldt U, Birkemeyer R, Treusch F, Kunze M, Jung W. Persistent atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol. 2008;22: 177-181.
7. De Ponti R, Cappato R, Curnis A, Della Bella P, Padeletti L, Raviele A, Santini M, Salerno-Uriarte JA. Trans-septal catheterization in the elec-trophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol. 2006;47:1037-1042.
8. Chierchia GB, de Asmundis C, Muller-Burri SA, Sarkozy A, Capulzini L, Paperella G, Chierchia S, Roos M, Brugada P. Early recovery of pulmonary vein conduction after cryoballoon ablation for paroxysmal atrial fibrillation: a prospective study. Europace. 2008; 11:445-449.
9. AGA Medical Corporation. Amplatzer Cardiac Plug: Instructions for use. Available at: http://international.amplatzer.com/portals/againtl/uploaded-docs/ 600286-011-AMPLATZER-CardiacPlug-Instructions-For-Use-OUS-Only-01-11-10.pdf.
10. Rilling A, Meyerfeldt U, Kunze M, Birkemeyer R, Miljak T, Jackle S, Hajredini B, Treusch F, Jung W. Persistent iatrogenic atrial septal defect after a single puncture, double transseptal approach for pulmonary vein isolation using a remote robotic navigation system: results from a prospective study. Europace. 2010;12:331-336.
11. Sur JP, Pagani FD, Moscucci M. Percutaneous closure of an iatrogenic atrial septal defect. Catheter Cardiovasc Interv. 2009;73:267-271.
12. Ussia GP, Barbanti M, Tamburino C. Feasibility of percutaneous trans-catheter mitral valve repair with the MitraClip system using conscious sedation. Catheter Cardiovasc Interv. 2010;75:1137-1140.
13. Kronzon I, Ruiz CE. Diagnosing patent foramen ovale: too much or too little. J Am Coll Cardiol Cardiovasc Imaging. 2010;3:349-351.
14. Chilukuri K, Sinha S, Berger R, Marine JE, Cheng A, Nazarian S, Scherr D, Spragg D, Calkins H, Henrikson CA. Association of transseptal punctures with isolated migraine aura in patients undergoing catheter ablation of cardiac arrhythmias. J Cardiovasc Electrophysiol. 2009;20:1227-1230.